Lupin Must Halt Sales Of Generic Diabetes Drug: Judge
A federal judge on Tuesday ordered Lupin Ltd. to stop selling its generic version of Type 2 diabetes treatment Fortamet, the subject of a patent infringement suit, but denied patent holder...To view the full article, register now.
Already a subscriber? Click here to view full article